[
If the stock closes at or near its peak, it would mark the largest first-day pop for a US IPO raising more than $100 million since CureVac NV in 2020. CureVac’s shares closed 249% higher in debut and continued to soar before disappointing Covid-19 vaccine data drove a collapse in the biotech’s stock price.
The offering of 34 million shares by Circle and backers including co-founder and Chief Executive Officer Jeremy Allaire was increased from 32 million shares, and had been marketed at $27 to $28 each.
https://img.etimg.com/thumb/msid-121661503,width-1200,height-630,imgsize-11632,overlay-etmarkets/articleshow.jpg
https://economictimes.indiatimes.com/markets/cryptocurrency/stablecoin-firm-circle-triples-after-ipo-priced-above-range/articleshow/121661437.cms